Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
Titel:
Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial
Auteur:
Pérez-García, José Manuel Gebhart, Geraldine Ruiz Borrego, Manuel Stradella, Agostina Bermejo, Begoña Schmid, Peter Marmé, Frederik Escrivá-de-Romani, Santiago Calvo, Lourdes Ribelles, Nuria Martinez, Noelia Albacar, Cinta Prat, Aleix Dalenc, Florence Kerrou, Khaldoun Colleoni, Marco Afonso, Noemia Di Cosimo, Serena Sampayo-Cordero, Miguel Malfettone, Andrea Cortés, Javier Llombart-Cussac, Antonio